22.4(top 1%)
Impact Factor
23.7(top 1%)
extended IF
115(top 3%)
H-Index
1.6K
authors
1.6K
papers
63.8K
citations
3.6K
citing journals
45K
citing authors

Most Cited Articles of Journal of Hematology and Oncology

TitleYearCitations
The effects of beta-glucan on human immune and cancer cells2009498
Exosomes in cancer: small particle, big player2015475
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers2013446
The biology and role of CD44 in cancer progression: therapeutic implications2018432
Tumor-associated macrophages: from basic research to clinical application2017398
Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma2015380
Next generation of immune checkpoint therapy in cancer: new developments and challenges2018375
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications2019375
Ferroptosis, a new form of cell death: opportunities and challenges in cancer2019330
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents2010327
Clinical applications of mesenchymal stem cells2012317
Long non-coding RNA: a new player in cancer2013313
Mechanism of action of lenalidomide in hematological malignancies2009299
Functions of lncRNA HOTAIR in lung cancer2014265
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-192020265
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy2019262
Wnt/beta-catenin pathway: modulating anticancer immune response2017257
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics2019256
Diverse functions of miR-125 family in different cell contexts2013255
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma2018252
Targeting mTOR for cancer therapy2019245
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer2013230
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel2018224
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy2016221
An evolving new paradigm: endothelial cells--conditional innate immune cells2013219